With the upcoming watchOS 4 update for Apple Watch slated to bring new features for diabetes management devices, we took some time to speak with Dexcom’s CEO Kevin Sayer this week about what it means for users. When Apple revealed watchOS 4 at its Worldwide Developers Conference this month, it featured Dexcom, makers of the G5 Continuous Glucose Monitor (CGM) popular among iPhone users, on stage as an example of an Apple Watch app that will benefit from new features in the release.
Sayer shared details on how exactly Dexcom devices will improve from these new features in watchOS 4, and more specifically why CoreBluetooth support will be a “game changer” for Apple Watch users with diabetes.
We also learned from Sayer about the next-generation of the company’s popular G5 CGM coming soon. And we had to ask about the chatter prior to WWDC that Apple is reportedly developing its own glucose monitoring technology, to find out his thoughts on the possibility of such features being built directly into future Apple Watch models.
expand full story